
Keywords: Adenosine; Adenosine receptor; Drug target; Drug discovery; Pharmacology; Disease; T1D; type 1 diabetes; T2D; type 2 diabetes; A1AR; A1 adenosine receptor; A2AAR; A2A adenosine receptor; A2BAR; A2B adenosine receptor; A3AR; A3 adenosine receptor;